First Trust Advisors
GMAB icon

First Trust Advisors’s Genmab GMAB Stock Holding History

First Trust Advisors’s Portfolio GMAB Stock Details GMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$66M Buy
2,461,342
+1,126,069
+84% +$33.7M 0.05% 476
2025
Q4 		$41.1M Sell
1,335,273
-352,115
-21% -$11M 0.03% 644
2025
Q3 		$51.8M Sell
1,687,388
-82,922
-5% -$2.02M 0.04% 547
2025
Q2 		$36.6M Buy
1,770,310
+60,504
+4% +$1.24M 0.03% 696
2025
Q1 		$33.5M Buy
1,709,806
+65,518
+4% +$1.37M 0.03% 692
2024
Q4 		$34.3M Buy
1,644,288
+251,241
+18% +$5.52M 0.03% 673
2024
Q3 		$34M Buy
1,393,047
+184,074
+15% +$4.92M 0.03% 626
2024
Q2 		$30.4M Sell
1,208,973
-20,597
-2% -$584K 0.03% 645
2024
Q1 		$36.8M Sell
1,229,570
-40,525
-3% -$1.19M 0.04% 580
2023
Q4 		$40.4M Buy
1,270,095
+175,292
+16% +$5.5M 0.04% 486
2023
Q3 		$38.6M Sell
1,094,803
-99,303
-8% -$3.78M 0.05% 485
2023
Q2 		$45.4M Sell
1,194,106
-80,887
-6% -$3.22M 0.05% 470
2023
Q1 		$48.1M Buy
1,274,993
+79,840
+7% +$3.07M 0.06% 456
2022
Q4 		$50.7M Sell
1,195,153
-96,347
-7% -$3.97M 0.06% 447
2022
Q3 		$41.5M Buy
+1,291,500
New +$45.3M 0.05% 472
2022
Q2 		– Sell
-77,538
Closed -$2.81M – 2535
2022
Q1 		$2.81M Sell
77,538
-66,941
-46% -$2.3M ﹤0.01% 1637
2021
Q4 		$5.72M Sell
144,479
-171,287
-54% -$7.14M 0.01% 1305
2021
Q3 		$13.8M Sell
315,766
-164,722
-34% -$7.39M 0.01% 910
2021
Q2 		$19.6M Buy
+480,488
New +$18.5M 0.02% 788
2021
Q1 		– Sell
-719,688
Closed -$29.3M – 2426
2020
Q4 		$29.3M Buy
719,688
+353,483
+97% +$13.2M 0.04% 518
2020
Q3 		$13.4M Buy
366,205
+228,434
+166% +$8.26M 0.02% 636
2020
Q2 		$4.67M Buy
137,771
+72,131
+110% +$1.97M 0.01% 1009
2020
Q1 		$1.39M Buy
65,640
+29,854
+83% +$665K ﹤0.01% 1460
2019
Q4 		$799K Buy
+35,786
New +$781K ﹤0.01% 1970

Other funds holding GMAB

OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
HL
Harding Loevner Bridgewater, New Jersey $9.72B AUM 22.38% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

First Trust Advisors's GMAB Position: Q1 2026 in Review

First Trust Advisors increased its Genmab (GMAB) stake by 84% in Q1 2026, buying an estimated $33.7M and bringing the position to 2,461,342 shares worth $66M. The position accounts for 0.05% of the portfolio, ranked #476.

First Trust Advisors first reported a position in GMAB in Q4 2019 and has held it in 24 quarters since. 272 funds tracked by Wall St. Rank hold GMAB as of Q1 2026.

  • First Trust Advisors held 2,461,342 shares of Genmab worth $66M as of Q1 2026.
  • First Trust Advisors bought 1,126,069 Genmab shares in Q1 2026, an estimated $33.7M.
  • Genmab made up 0.05% of First Trust Advisors's portfolio in Q1 2026, its #476 holding.
  • First Trust Advisors first reported a position in Genmab in Q4 2019 and has held it in 24 quarters since.
  • 272 funds tracked by Wall St. Rank held Genmab as of Q1 2026.

Based on First Trust Advisors's 13F filing for Q1 2026, filed 13 May 2026.